Aurobindo Pharma Ltd
BSE : 524804
NSE : AUROPHARMA
Sector :Health care
ISIN Code : INE406A01037
NSE
1269.95
13.70 (1.09%)
Open
1255.00
High
1275.00
Low
1251.80
BSE
1269.00
11.95 (0.95%)
Open
1255.95
High
1274.00
Low
1251.80
Announcement under Regulation 30 (LODR)-Press Release / Media Release
04:01 PM,27th Dec 2024
Submission of Press Release that is being issued announcing that Curateq Biologics s.r.o a wholly owned step down subsidiary of the Company has obtained marketing authorisation from U.Ks Medicines and Healthcare products Regulatory Agency (MHRA) for Bevgolva its bevacizumab biosimilar version.
